Idarucizumab for a traumatic head injury patient taking dabigatran

Maruyama, S; Hayakawa, K; Kanayama, S; Iwamura, H; Wada, D; Saito, F; Nakamori, Y; Kuwagata, Y

Maruyama, S (reprint author), Kansai Med Univ, Dept Emergency & Crit Care Med, Med Ctr, 10-15 Fumizono Cho, Moriguchi, Osaka 5708507, Japan.

INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE, 2018; 11 ():

Abstract

Background: Dabigatran is one of the four drugs currently used as a direct oral anticoagulant in Japan. Idarucizumab, which specifically targets dabig......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索